NanoView Biosciences, Inc.
Biotechnology company · Boston, Massachusetts, United States
NanoView Biosciences, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $578,923 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2022.
NanoView Biosciences at a glance
What does NanoView Biosciences do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $578,923 in total (2017 to 2021). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2.5 million sold (2022).
Frequently asked questions about NanoView Biosciences
Where is NanoView Biosciences headquartered?
NanoView Biosciences, Inc. is headquartered in Boston, Massachusetts, United States.
What does NanoView Biosciences do?
NanoView Biosciences, Inc. is a biotechnology company.
When was NanoView Biosciences founded?
The earliest incorporation on record for NanoView Biosciences, Inc. is in 2015, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences